V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20027284 | 20011610 | 1.8 | 65.5 | Adjuvant (A) | 2016-01-03 | 2016-01-19 | FEC + DOCETAXEL | 02 | N | 20096133 | FEC + DOCETAXEL |
| 20027285 | 20011611 | 1.61 | 122.5 | Adjuvant (A) | 2015-08-31 | 2015-09-04 | FEC + DOCETAXEL | 02 | N | 20096134 | FEC + DOCETAXEL |
| 20027286 | 20011611 | 1.58 | null | Neo-adjuvant (N) | 2016-06-07 | 2016-07-02 | FEC + DOCETAXEL | 1 | N | 20096134 | FEC + DOCETAXEL |
| 20027287 | 20011612 | 1.62 | 59.9 | Neo-adjuvant (N) | 2017-07-17 | 2017-07-17 | FEC 100 + DOCETAXEL | 02 | N | 20096139 | FEC + DOCETAXEL |
| 20027288 | 20011612 | 1.68 | 49.5 | Not known (9) | 2016-01-01 | 2016-01-01 | FEC + DOCETAXEL | 02 | N | 20096139 | FEC + DOCETAXEL |
| 20027289 | 20011613 | 1.55 | 68 | Adjuvant (A) | 2015-05-20 | 2015-06-03 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20096147 | FEC + DOCETAXEL |
| 20027290 | 20011614 | 1.57 | 76.6 | Not known (9) | 2015-07-12 | 2015-07-19 | FEC + DOCETAXEL | 2 | N | 20096150 | FEC + DOCETAXEL |
| 20027291 | 20011614 | 1.61 | 99 | Adjuvant (A) | 2016-06-04 | 2016-06-09 | FEC + DOCETAXEL | N | N | 20096150 | FEC + DOCETAXEL |
| 20027292 | 20011614 | 1.68 | 83 | Adjuvant (A) | 2015-01-28 | 2015-02-08 | FEC 100 + DOCETAXEL | 02 | N | 20096150 | FEC + DOCETAXEL |
| 20027293 | 20011614 | 1.74 | 77.3 | Adjuvant (A) | 2013-09-18 | 2013-09-28 | FEC + DOCETAXEL | 02 | N | 20096150 | FEC + DOCETAXEL |
| 20027294 | 20011615 | 1.47 | null | null | 2016-11-30 | 2016-12-31 | FEC 100 + DOCETAXEL | N | N | 20096160 | FEC + DOCETAXEL |
| 20027295 | 20011615 | 1.64 | 74 | Adjuvant (A) | 2016-03-06 | 2016-03-20 | FEC 100 + DOCETAXEL | 02 | null | 20096160 | FEC + DOCETAXEL |
| 20027296 | 20011616 | 1.58 | 118.8 | Adjuvant (A) | 2017-06-02 | 2017-06-12 | FEC + DOCETAXEL | 2 | N | 20096163 | FEC + DOCETAXEL |
| 20027297 | 20011616 | 1.58 | 0 | Neo-adjuvant (N) | 2016-03-15 | 2016-03-15 | FEC + DOCETAXEL | 2 | null | 20096163 | FEC + DOCETAXEL |
| 20027298 | 20011616 | 1.63 | null | null | 2017-02-13 | 2017-03-21 | FEC + DOCETAXEL | N | N | 20096163 | FEC + DOCETAXEL |
| 20027299 | 20011616 | 1.59 | 76.6 | Adjuvant (A) | 2013-08-28 | 2013-09-01 | FEC 100 + DOCETAXEL | 02 | N | 20096163 | FEC + DOCETAXEL |
| 20027300 | 20011616 | 1.6 | 48 | Disease modification (D) | 2013-06-05 | 2013-06-18 | FEC 100 + DOCETAXEL | 2 | N | 20096163 | FEC + DOCETAXEL |
| 20027301 | 20011616 | 1.58 | 89.4 | a | 2016-04-01 | 2016-04-01 | FEC + DOCETAXEL | N | N | 20096163 | FEC + DOCETAXEL |
| 20027302 | 20011616 | 1.58 | 42 | Adjuvant (A) | 2014-03-04 | 2014-03-14 | FEC + DOCETAXEL | 02 | N | 20096163 | FEC + DOCETAXEL |
| 20027303 | 20011616 | 1.67 | 66 | Adjuvant (A) | 2014-01-26 | 2014-02-09 | FEC 100 + DOCETAXEL | N | N | 20096163 | FEC + DOCETAXEL |
| 20027304 | 20011616 | null | 67.8 | Adjuvant (A) | 2018-04-21 | 2018-05-02 | FEC + DOCETAXEL | N | N | 20096163 | FEC + DOCETAXEL |
| 20027305 | 20011617 | 1.62 | 61.6 | Adjuvant (A) | 2016-01-01 | 2016-01-20 | FEC + DOCETAXEL | N | N | 20096194 | FEC + DOCETAXEL |
| 20027306 | 20011617 | 1.71 | 63 | Not known (9) | 2013-05-16 | 2013-06-02 | FEC + DOCETAXEL | 02 | N | 20096194 | FEC + DOCETAXEL |
| 20027307 | 20011618 | 1.58 | 53.2 | Adjuvant (A) | null | 2016-01-08 | FEC + DOCETAXEL | N | N | 20096203 | FEC + DOCETAXEL |
| 20027308 | 20011618 | null | 72 | Adjuvant (A) | 2015-07-02 | 2015-07-02 | FEC 100 + DOCETAXEL | N | N | 20096203 | FEC + DOCETAXEL |
| 20027309 | 20011619 | 1.67 | 81 | Adjuvant (A) | null | 2015-05-06 | FEC + DOCETAXEL | Y | N | 20096216 | FEC + DOCETAXEL |
| 20027310 | 20011619 | 1.62 | 63 | Adjuvant (A) | 2016-05-11 | 2016-05-24 | FEC 100 + DOCETAXEL | N | N | 20096216 | FEC + DOCETAXEL |
| 20027311 | 20011620 | 1.63 | null | Adjuvant (A) | 2013-10-29 | 2013-11-08 | FEC + DOCETAXEL | null | N | 20096227 | FEC + DOCETAXEL |
| 20027312 | 20011620 | 1.65 | null | Curative (C) | 2014-07-08 | 2014-09-27 | FEC 60 OR 75 + DOCETAXEL | N | N | 20096227 | FEC + DOCETAXEL |
| 20027313 | 20011621 | 0 | 102 | Neo-adjuvant (N) | 2015-08-12 | 2015-08-21 | FEC 100 + DOCETAXEL | N | N | 20096230 | FEC + DOCETAXEL |
| 20027314 | 20011621 | 1.73 | 68.1 | Adjuvant (A) | 2017-06-04 | 2017-06-04 | FEC + DOCETAXEL | 02 | N | 20096230 | FEC + DOCETAXEL |
| 20027315 | 20011622 | 1.69 | 91.6 | Not known (9) | 2014-05-23 | 2014-05-23 | FEC + DOCETAXEL | 02 | N | 20096242 | FEC + DOCETAXEL |
| 20027316 | 20011623 | null | 79 | Adjuvant (A) | 2017-03-27 | 2017-04-19 | FEC + DOCETAXEL | 99 | null | 20096244 | FEC + DOCETAXEL |
| 20027317 | 20011623 | 1.58 | 55 | Adjuvant (A) | 2014-12-06 | 2014-12-19 | FEC + DOCETAXEL | 02 | null | 20096244 | FEC + DOCETAXEL |
| 20027318 | 20011624 | 1.65 | 69.5 | Adjuvant (A) | 2015-08-12 | 2015-08-31 | FEC + DOCETAXEL | 2 | N | 20096250 | FEC + DOCETAXEL |
| 20027319 | 20011625 | 1.71 | 72 | Adjuvant (A) | 2018-01-27 | 2018-01-31 | FEC + DOCETAXEL | 2 | N | 20096252 | FEC + DOCETAXEL |
| 20027320 | 20011625 | 1.5 | 63 | Adjuvant (A) | 2013-07-03 | 2013-08-01 | FEC 100 + DOCETAXEL | N | N | 20096252 | FEC + DOCETAXEL |
| 20027321 | 20011626 | 1.65 | 69.5 | Neo-adjuvant (N) | 2013-10-25 | 2013-11-02 | FEC + DOCETAXEL | N | N | 20096256 | FEC + DOCETAXEL |
| 20027322 | 20011626 | 1.62 | 70.4 | Curative (C) | 2014-08-19 | 2014-09-10 | FEC + DOCETAXEL | N | N | 20096256 | FEC + DOCETAXEL |
| 20027323 | 20011627 | 1.66 | 62 | Adjuvant (A) | 2014-05-08 | 2014-05-11 | FEC 100 + DOCETAXEL | 2 | N | 20096267 | FEC + DOCETAXEL |
| 20027324 | 20071885 | null | 70 | Adjuvant (A) | null | 2016-01-21 | FEC + DOCETAXEL | N | N | 20096270 | FEC + DOCETAXEL |
| 20027325 | 20011628 | null | null | Neo-adjuvant (N) | 2013-12-28 | 2014-01-24 | FEC 100 + DOCETAXEL | N | N | 20096275 | FEC + DOCETAXEL |
| 20027326 | 20011628 | 1.69 | 69 | Adjuvant (A) | 2015-05-13 | 2015-05-25 | FEC + DOCETAXEL | 02 | null | 20096275 | FEC + DOCETAXEL |
| 20027327 | 20011629 | 1.73 | 62.8 | Neo-adjuvant (N) | 2014-05-24 | 2014-05-24 | FEC + DOCETAXEL | 2 | N | 20096282 | FEC + DOCETAXEL |
| 20027328 | 20011630 | 1.69 | 78.2 | Adjuvant (A) | 2013-07-17 | 2013-07-19 | FEC + DOCETAXEL | 2 | N | 20096285 | FEC + DOCETAXEL |
| 20027329 | 20011630 | 1.72 | 58.3 | null | 2013-09-29 | 2013-09-30 | FEC + DOCETAXEL | 2 | N | 20096285 | FEC + DOCETAXEL |
| 20027330 | 20011630 | null | 64 | Not known (9) | 2015-09-13 | 2015-09-13 | FEC + DOCETAXEL | 2 | N | 20096285 | FEC + DOCETAXEL |
| 20027331 | 20011630 | null | null | Adjuvant (A) | 2014-11-14 | 2014-11-14 | FEC 100 + DOCETAXEL | N | N | 20096285 | FEC + DOCETAXEL |
| 20027332 | 20011630 | 1.58 | 80.4 | Adjuvant (A) | null | 2015-11-27 | FEC + DOCETAXEL | N | N | 20096285 | FEC + DOCETAXEL |
| 20027333 | 20011631 | 1.62 | 77 | Adjuvant (A) | 2013-11-11 | 2013-11-12 | FEC + DOCETAXEL | 02 | N | 20096305 | FEC + DOCETAXEL |